More on ALGS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aligos Therapeutics Inc. (NQ:ALGS)
Delayed: 5.55 -0.01 (0.18%)
Prev. Close $5.56  
Open$5.55 
52 Wk High$ 
52 Wk Low$ 
Day High$5.70 
Day Low$5.27 
P/E N/A  
EPS$ 
Volume59,871 


Sep 15, 2026 04:03 PM Form 8-K Aligos Therapeutics, For: Sep 10
Sep 2, 2026 08:00 AM Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
Aug 12, 2026 04:05 PM Aligos partner doses first participant in ALG-170675 Phase 1 trial
Aug 12, 2026 04:05 PM Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
Aug 10, 2026 06:49 AM H.C. Wainwright Reiterates Buy Rating on Aligos Therapeutics Inc. (ALGS)
Aug 6, 2026 04:05 PM Form S-8 Aligos Therapeutics,
Aug 6, 2026 08:46 AM Aligos Therapeutics Inc. (ALGS) Tops Q2 EPS by 101c
Aug 6, 2026 08:08 AM Form 10-Q Aligos Therapeutics, For: Jun 30
Aug 6, 2026 08:01 AM Form 8-K Aligos Therapeutics, For: Aug 06
Aug 6, 2026 08:00 AM Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
View All Articles

Entities mentioned with ALGS

View All Entities